The stock could break the range it's been in over the past two months.
Pharmacy chain also confirms full-year EPS guidance but 2Q profit guidance falls short of consensus expectations.
We highlight this name as a higher beta tech stock.
It shows a pullback toward an ideal entry point.
A preview ahead of tomorrow's earnings.
A nice, tight upward channel is in place.
Several portfolio names outperformed the market this week as April exited with a whimper instead of a bang.
04/29/16 - 08:55 AM EDT
ERIC, YUM, WFM, HVT and AGNC were all recently downgraded by TheStreet’s Quant Ratings.
The stock is showing strength.